11 employees
Rappta Therapeutics is a lead-optimization stage biopharmaceutical company.
2006
$11M
from 2 investors over 2 rounds
Rappta Therapeutics raised $11M on October 13, 2020
Investors: Advent Life Sciences and Novo Holdings